REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$11.42
Tradestie Score
63
Market Cap
$328.62M
Analyst Upside
-59.1%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.35
|
$951.83M | - | 59 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$20.21
|
$931.48M | - | 61 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$17.44
|
$917.23M | - | 59 | Compare |
|
OCS
Oculis Holding AG Ordinary shares
|
$11.72
|
$910.64M | - | 57 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$25.00
|
$906.29M | - | 55 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$36.60
|
$903.54M | - | 48 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$83.40
|
$900.91M | - | 54 | Compare |
|
GERN
Geron Corp
|
$1.35
|
$899.60M | - | 61 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$59.43
|
$894.30M | - | 58 | Compare |
More REPL Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry